A DYNAMIC TRANSMISSION MODEL TO ESTIMATE THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF TRIVALENT INFLUENZA VACCINE HIGH DOSE FOR THE ELDERLY POPULATION IN ENGLAND AND WALES

被引：3
|
作者：
Crepey, P. [1 ]
Skinner, L. [2 ]
Carroll, S. [2 ]
Bricout, H. [3 ]
Jacob, J. [4 ]
Largeron, N. [3 ]
Alvarez, F. P. [3 ]
Clark-Wright, J. [2 ]
机构：
[1] Univ Rennes, Rennes, France
[2] Sanofi Pasteur, Maidenhead, Berks, England
[3] Sanofi Pasteur, Lyon, France
[4] Syneos, London, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1352
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN33
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [1] AN ECONOMIC MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF TRIVALENT INFLUENZA VACCINE HIGH DOSE FOR THE ELDERLY POPULATION IN ENGLAND AND WALES
    Jacob, J.
    Bianic, F.
    Skinner, L.
    Carroll, S.
    Bricout, H.
    Largeron, N.
    Alvarez, F. P.
    Clark-Wright, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S225 - S225
  • [2] Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and Wales
    Mattock, Richard
    Gibbons, Ilana
    Moss, Joe
    Mealing, Stuart
    Largeron, Nathalie
    Carroll, Stuart
    Alvarez, Fabian P.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1261 - 1271
  • [3] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND
    Gibbons, I
    Davidson, C.
    Clark-Wright, J.
    Miller, C.
    Carroll, S.
    Costa, M.
    Bricout, H.
    Alvarez, F. P.
    [J]. VALUE IN HEALTH, 2020, 23 : S554 - S554
  • [4] AN ECONOMIC MODEL TO ESTIMATE THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF VACCINATION OF SENIORS WITH FLUZONE HIGH DOSE INFLUENZA VACCINE IN AUSTRALIA
    Largeron, N.
    Manton, A.
    Net, P.
    Choi, S.
    Becker, D. L.
    Bianic, F.
    Jacob, J.
    Maschio, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [5] Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China
    Jiang, Minghuan
    Li, Pengchao
    Wang, Weihua
    Zhao, Mingyue
    Atif, Naveel
    Zhu, Shan
    Fang, Yu
    [J]. VACCINE, 2020, 38 (05) : 1057 - 1064
  • [6] Cost-effectiveness and budget impact analysis for high dose quadrivalent influenza vaccine in the Italian elderly population
    Rumi, Filippo
    Basile, Michele
    Cicchetti, Americo
    [J]. GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2021, 8 : 105 - 113
  • [7] Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model
    Pitman, R. J.
    Nagy, L. D.
    Sculpher, M. J.
    [J]. VACCINE, 2013, 31 (06) : 927 - 942
  • [8] THE POTENTIAL COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INACTIVATED INFLUENZA VACCINE FOR THE PORTUGUESE ELDERLY POPULATION
    Tavares, D.
    Martin Saborido, C.
    Mourino, H.
    Anton Rodriguez, C.
    [J]. VALUE IN HEALTH, 2019, 22 : S651 - S652
  • [9] Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal
    Alvarez, Fabian P.
    Chevalier, Pierre
    Borms, Matthias
    Bricout, Helene
    Marques, Catia
    Soininen, Anu
    Sainio, Tatu
    Petit, Christine
    de Courville, Caroline
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 710 - 719
  • [10] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    You, Joyce H. S.
    Ming, Wai-kit
    Chan, Paul K. S.
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
12345